Lysine

Lysine

SCHEMBL5575951

C[C@H](N)C(=O)O.NCCCC[C@H](N)C(=O)O.O=C(O)[C@@H]1CCCN1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.51
DPP7 Q9UHL4 7/20 0.38
DPP4 P27487 4/20 0.38
DPP8 Q6V1X1 3/20 0.38
DPP9 Q86TI2 2/20 0.38
FAP Q12884 1/20 0.36
ARG1 P05089 3/20 0.35
ARG2 P78540 3/20 0.35
NOS3 P29474 2/20 0.35
NOS1 P29475 2/20 0.35
NOS2 P35228 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL29069496 1.00 GSR (0.51) GSRDPP7DPP4DPP8DPP9
Lysine SCHEMBL1675274 1.00 GSR (0.51) GSRDPP7DPP4DPP8DPP9
Lysine SCHEMBL18263286 0.96 GSR (0.48) GSRDPP7DPP4DPP8DPP9
Lysine SCHEMBL18259132 0.96 GSR (0.48) GSRDPP7DPP4DPP8DPP9
Lysine SCHEMBL17728306 0.95 GSR (0.47) GSRDPP7DPP4DPP8DPP9
Lysine SCHEMBL23834597 0.95 GSR (0.57) GSRDPP7DPP4DPP8DPP9
Lysine SCHEMBL5227175 0.95 GSR (0.57) GSRDPP7DPP4DPP8DPP9
Lysine SCHEMBL4296375 0.95 GSR (0.57) GSRDPP7DPP4DPP8DPP9
Lysine SCHEMBL1696608 0.95 GSR (0.57) GSRDPP7DPP4DPP8DPP9
Lysine SCHEMBL11660661 0.95 GSR (0.57) GSRDPP7DPP4DPP8DPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2958971-B1 MULTI COMPONENT ADHESIVE FOR THE PREPARATION OF ADHESIVE HYDROGELS FRAUNHOFER GES FORSCHUNG (DE) 2018-07-11 EP claimed
US-20160130484-A1 MULTI-COMPONENT ADHESIVE FOR PRODUCING AN ADHESIVE HYDROGEL Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2016-05-12 US claimed
CN-117580584-A Peptide modified nanoparticles for enrichment of specific protein subsets 禧尔公司 2024-02-20 CN disclosed
US-20160130484-A1 MULTI-COMPONENT ADHESIVE FOR PRODUCING AN ADHESIVE HYDROGEL Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2016-05-12 US disclosed
US-7276341-B2 Octapeptides for detection and treatment of autoimmune disorders OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) 2007-10-02 US disclosed
US-6897287-B1 Ro/SSA peptide reagents for diagnosis of autoantibodies OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) 2005-05-24 US disclosed
US-20030216544-A1 Methods and reagents for diagnosis of autoantibodies BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA 2003-11-20 US disclosed
US-6641813-B1 Octapeptides were generated from the sequences encoding the 60 kDa Ro/SSA peptide, the La/SSB autoantigen, the 70 kD nuclear ribonucleoprotein (nRNP), and the Sm B/B' polypeptide, which represent linear epitopes for autoantibodies presence of blood OKLAHOMA MEDICAL RESEARCH FOUNDATION 2003-11-04 US disclosed
EP-0640101-B1 METHODS AND REAGENTS FOR DIAGNOSIS OF AUTOANTIBODIES OKLAHOMA MED RES FOUND (US) 1999-12-08 EP disclosed
EP-0640101-A4 METHODS AND REAGENTS FOR DIAGNOSIS OF AUTOANTIBODIES. UNIV OKLAHOMA STATE (US) 1995-06-21 EP disclosed
EP-0640101-A1 METHODS AND REAGENTS FOR DIAGNOSIS OF AUTOANTIBODIES BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) 1995-03-01 EP disclosed
WO-1993021223-A1 METHODS AND REAGENTS FOR DIAGNOSIS OF AUTOANTIBODIES BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) 1993-10-28 WO disclosed